Annexon, Inc. (ANNX)
NASDAQ: ANNX · Real-Time Price · USD
4.010
+0.600 (17.60%)
At close: Oct 19, 2026, 4:00 PM EDT
4.010
0.00 (-0.01%)
Pre-market: Oct 20, 2026, 8:59 AM EDT
Annexon Market Cap
Annexon has a market cap or net worth of $760.21 million as of October 19, 2026. It is the 11,809th most valuable company in the world and the 2,410th biggest in the United States. Its market cap has increased by 119.62% in one year.
Market Cap
760.21M
Enterprise Value
575.62M
1-Year Change
119.62%
Global Rank
Country Rank
#2,410 United States
Category
ChartMarket Cap Chart
Since July 24, 2020, Annexon's market cap has increased from $639.51M to $760.21M, an increase of 18.87%. That is a compound annual growth rate of 2.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 760.21M | 1.60% |
| Dec 31, 2025 | 748.26M | 36.84% |
| Dec 31, 2024 | 546.82M | 53.75% |
| Dec 29, 2023 | 355.65M | 44.43% |
| Dec 30, 2022 | 246.25M | -44.15% |
| Dec 31, 2021 | 440.93M | -53.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 4D Molecular Therapeutics | 671.77M |
| OmniAb | 667.34M |
| Pharming Group | 667.25M |
| Immix Biopharma | 661.57M |
| Achieve Life Sciences | 656.52M |
| MiMedx Group | 645.72M |
| Design Therapeutics | 645.22M |
| Gyre Therapeutics | 644.69M |